These results suggest that apoptosis significantly contributes to MMRi36’s anti-lymphoma effect in p53-mutant lymphoma cells but contributes little to the MMRi36’s anti-lymphoma effect in RRCL cells. This evidence concerns the gene TP53 and lymphoma.